Tokyo Tape
Sign in
← Kyowa Kirin

Annual report

4151.TEDINET S100VDMK
Period2024-01-01 → 2024-12-31
Filed2025-03-11
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 155
MetricValuePeriodScopeSource row
Revenue¥495.6bn2024-01-01 → 2024-12-31Cons.Revenue IFRS
Revenue¥442.2bn2023-01-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥398.4bn2022-01-01 → 2022-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥352.2bn2021-01-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥318.4bn2020-01-01 → 2020-12-31dCons.Revenue IFRS (5-year summary)
Profit before tax¥83.5bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS
Profit before tax¥97.2bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥67.6bn2022-01-01 → 2022-12-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥60.0bn2021-01-01 → 2021-12-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥52.3bn2020-01-01 → 2020-12-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥59.9bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥81.2bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥53.6bn2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥52.3bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥47.0bn2020-01-01 → 2020-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥59.9bn2024-01-01 → 2024-12-31Cons.Profit loss IFRS
Net income¥81.2bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS
Total assets¥1.07Tat 2024-12-31Cons.Assets IFRS
Total assets¥1.03Tat 2023-12-31Cons.Assets IFRS
Total assets¥939.9bnat 2022-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥921.9bnat 2021-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥801.3bnat 2020-12-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥216.6bnat 2024-12-31Cons.Liabilities IFRS
Total liabilities¥189.5bnat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥850.8bnat 2024-12-31Cons.Equity IFRS
Net assets / equity¥836.4bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥762.8bnat 2022-12-31dCons.Equity IFRS
Equity (owners)¥850.8bnat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥836.4bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥762.8bnat 2022-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥737.2bnat 2021-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥698.4bnat 2020-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥244.7bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥403.1bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥339.2bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥335.1bnat 2021-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥287.0bnat 2020-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥67.9bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥115.6bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥48.7bn2022-01-01 → 2022-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥86.5bn2021-01-01 → 2021-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥39.5bn2020-01-01 → 2020-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥142.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥20.4bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.2bn2022-01-01 → 2022-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥11.4bn2021-01-01 → 2021-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥252.6bn2020-01-01 → 2020-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥84.7bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥32.5bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥29.0bn2022-01-01 → 2022-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥28.4bn2021-01-01 → 2021-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥26.0bn2020-01-01 → 2020-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥113.062024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥151.032023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥99.682022-01-01 → 2022-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥97.432021-01-01 → 2021-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥87.562020-01-01 → 2020-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥113.062024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥151.012023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥99.662022-01-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥97.392021-01-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥87.52020-01-01 → 2020-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,625.68at 2024-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,555.81at 2023-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,419.27at 2022-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,371.9at 2021-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,300.12at 2020-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio79.7%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio81.5%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio81.2%at 2022-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio80.0%at 2021-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio87.2%at 2020-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE7.1%2024-01-01 → 2024-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE10.2%2023-01-01 → 2023-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE7.1%2022-01-01 → 2022-12-31dCons.Rate of return on equity IFRS (5-year summary)
ROE7.3%2021-01-01 → 2021-12-31dCons.Rate of return on equity IFRS (5-year summary)
ROE6.8%2020-01-01 → 2020-12-31dCons.Rate of return on equity IFRS (5-year summary)
Employees5,669at 2024-12-31Cons.Number of employees
Employees5,974at 2023-12-31Cons.Number of employees
Employees5,982at 2022-12-31dCons.Number of employees
Employees5,752at 2021-12-31dCons.Number of employees
Employees5,423at 2020-12-31dCons.Number of employees
Revenue¥286.5bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥277.2bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥253.8bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥237.6bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥252.9bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income−¥4.6bn2024-01-01 → 2024-12-31StandaloneOperating income
Operating income¥53.4bn2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income¥68.6bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income¥67.2bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥37.3bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥35.2bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥49.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥54.4bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax¥61.5bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income¥60.7bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income¥50.4bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥31.0bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income¥66.4bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥31.3bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥797.9bnat 2024-12-31StandaloneAssets
Total assets¥869.6bnat 2023-12-31StandaloneAssets
Total assets¥806.1bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥794.1bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥687.7bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥184.9bnat 2024-12-31StandaloneLiabilities
Total liabilities¥246.9bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥613.0bnat 2024-12-31StandaloneNet assets
Net assets / equity¥622.7bnat 2023-12-31StandaloneNet assets
Net assets / equity¥601.9bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥596.9bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥555.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥15.7bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥12.4bnat 2023-12-31StandaloneCash and deposits
EPS (basic)¥114.572024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥93.72023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥57.772022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.522021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥58.182020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥114.572024-01-01 → 2024-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥93.692023-01-01 → 2023-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥57.752022-01-01 → 2022-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥123.472021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥58.152020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥582024-01-01 → 2024-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥562023-01-01 → 2023-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥512022-01-01 → 2022-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥462021-01-01 → 2021-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥442020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,171.3at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,158.1at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,119.48at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,110.13at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,033.43at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio76.8%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.6%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio75.1%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.7%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE9.8%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE8.2%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE5.2%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE11.1%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE5.7%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued525,634,500at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued540,000,000at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued540,000,000at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued540,000,000at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued540,000,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees4,013at 2024-12-31StandaloneNumber of employees
Employees4,082at 2023-12-31StandaloneNumber of employees
Employees4,002at 2022-12-31dStandaloneNumber of employees
Employees3,857at 2021-12-31dStandaloneNumber of employees
Employees3,736at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceuticalsreportable segmentemployeesat 2024-12-315669 pure
Pharmaceuticalsreportable segmentemployeesat 2024-12-314013 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,933
ItemContextValueUnit
Number of employeesPrior3YearInstant_NonConsolidatedMember3857
Number of employeesPrior2YearInstant_NonConsolidatedMember4002
Number of employeesPrior1YearInstant_NonConsolidatedMember4082
Number of employeesCurrentYearInstant_NonConsolidatedMember4013
Total shareholder returnPrior4YearInstant_NonConsolidatedMember1.111
Total shareholder returnPrior3YearInstant_NonConsolidatedMember1.253
Total shareholder returnPrior2YearInstant_NonConsolidatedMember1.229
Total shareholder returnPrior1YearInstant_NonConsolidatedMember0.998
Total shareholder returnCurrentYearInstant_NonConsolidatedMember1.022
Total return on share price indexPrior4YearInstant_NonConsolidatedMember1.074
Total return on share price indexPrior3YearInstant_NonConsolidatedMember1.211
Total return on share price indexPrior2YearInstant_NonConsolidatedMember1.181
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.515
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.825
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00816-000PharmaceuticalsReportableSegmentMember5669
Number of employeesCurrentYearInstant5669
Number of employeesCurrentYearInstant_NonConsolidatedMember4013
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember43.2
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember16.5
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember9935667JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00816-000PharmaceuticalsReportableSegmentMember4013
Number of employeesCurrentYearInstant_NonConsolidatedMember4013
Ratio of female employees in managerial positions metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.155
All employees calculated based on provisions of act on promotion of womens active engagement in professional life ratio of male employees taking childcare leave metrics of reporting companyCurrentYearInstant_NonConsolidatedMember1.154
Regular employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.782
Non regular employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.648
All employees differences in wages between male and female employees metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.774
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E00816-000PharmaceuticalsReportableSegmentMember103500000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration29463000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember525634500
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember525634500
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant525634500
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant525634500
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember52
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember53
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember474
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember714
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember89
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember31705
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember33087
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember905453
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember167870
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember2940810
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember869032
Number of shares held number of units foreign individual investorsCurrentYearInstant_OrdinaryShareMember415
Number of shares held number of units individuals and othersCurrentYearInstant_OrdinaryShareMember367784
Number of shares held number of units totalCurrentYearInstant_OrdinaryShareMember5251364

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass